1. The main business of Tongze Medical Co. is medical services. The company's main products are medical services. The company is the vice chairman of Zhejiang Health Industry Federation, won the top 50 enterprises of China's pharmaceutical most competitive listed companies, was selected as one of Forbes China's top 100 most promising listed companies for five consecutive years, and has been listed on the Zhonglian Listed Companies Top 100 list for many times, was included in the MSCI China A-share Onshore Index in August 2018, and was ranked 18th in the 2019 China Capital Annual Conference Listed Companies Value Ranking TOP100 In August 2018, it was included in the MSCI China A-share Onshore Index, ranked 18th in the 2019 China Capital Conference Top 100 Listed Companies Value Ranking, won the 2019 Shanghai Securities News Listed Companies "Golden Quality - Most Growing Enterprise Award", and was selected as one of the top 200 Asian small and medium-sized listed companies by Forbes.
2, Tongze medical stock bar data show that the short-term trend of Tongze medical stock: the previous strong market has ended, investors sell stocks in time as appropriate. Medium-term trend: is in the rebound phase. Long-term trend: so far, ***174 main institutions, positions totaling 196 million shares, accounting for 61.02% of the outstanding A shares
3, Tong Ce medical stock recent average cost of 201.03 yuan, the stock price is running below the cost. In the short market, is currently in the rebound phase, investors can pay attention to. The stock is outflow in terms of funds, investors should invest with caution. The company's operating conditions are good, most organizations believe that the stock long-term investment value is high.
4, Tongtse Medical Co., Ltd. operational capacity has been strengthened, the main profitability to remain stable. Growth capacity has been strengthened, operating income growth rate increased significantly. Debt servicing capacity remains stable, with strong ability to repay current liabilities. Operational capacity remained stable, and the comprehensive utilization of assets was optimized. Cash flow capacity remained stable, and sustainable operating capacity was doubled.
5, Tongze medical operation model breaks the simple chain of oral health care institutions business model, adhere to its own "regional hospital + branch" model, the formation of its hospital brand, medical resource advantages, become the cornerstone of the competitiveness of Tongze medical. The company will build each regional headquarter into a leading hospital in terms of scale and level, and the regional headquarter platform will support the doctors' medical service skills and academic status, and form brand influence in the region, and the branch hospitals, as the "moat" of the headquarter, can push the brand influence to spread rapidly and realize the optimization of medical resources and the convenience of customers' medical treatment, thus accumulating customer resources in a relatively short time. In a short period of time, it can accumulate customer resources and gain market share. The development model of "regional headquarter + branch hospital" and the replication model of regional hospital grouping are still the main development direction of the company in the future.